D R LLOYD, E J HINDLE", J MARPLES and J A GATT" From the Department of Biochemistry. Royal Albert Edward Infirmary. Wigan WNI 2NN and "Department of Biochemistry. The Infirmary. Preston PRI 6PS. UK Sensitive assays for urine albumin are being used for the measurement of levels of protein which are above normal but below the limit of detection of commonly used tests for proteinuria. Laboratories are being increasingly required to measure these low concentrations of albumin in urine since this slight albuminuria may be associated with the development of diabetic nephropathy. ' We describe a simple automated 'in house' immunoturbidimetric (IT) assay for albumin in urine using a Cobas Bio centrifugal analyser (Roche Diagnostics, Welwyn Garden City, Herts, UK). Sathianathan, Rege and Barron/ have described a similar procedure. Our analysis, however, is preceded by a colorimetric protein assay on the Cobas Bio to screen for proteinuria in excess of 21K) mg/L which may cause antigen excess in the albumin assay. We have also assessed the IT assay by comparison with a commercially available radioimmunoassay (RIA) (Albumin, Diagnostic Products Corporation, Los Angeles, CA IJIK145, USA).
Materials and methods

SUB.IEeTS ANI) SAMPLES
Overnight timed specimens of urine were collected from children and adolescent volunteers (n=2X) with no history of diabetes or renal disease (mean age IJ·IJ years, range 4-16 years) and paediatric diabetic patients (n=46) (mean age 12 years, range 5-16 years). Volumes were measured and aliquots frozen at -200C. Cloudy specimens were centrifuged briefly to remove particulate matter on thawing and before analysis.
PROTEIN
Total urinary protein was estimated using absorbance mode analysis (Type I). Sample (30 !-tL), diluent (10 !-tL) and reagent (300 !-tL)
(Coomassie blue, protein assay reagent (Bio-Rad, Miinchen, West Germany) diluted 1:4 (v/v) with water) were incubated at 25°C and the change in absorbance at 595 nm measured between 0·5 sand 150 s. Absorbance from specimens in excess of that produced by a protein standard (200 mglL in 0·9% NaCl) required dilution for the albumin assay.
ALBUMIN
Albumin was estimated using autoblank endpoint analysis (Type 5). Sample (25 !-tL) and diluent (5 ul.) were added to reagent (250 !-tL) at 25°C after a 10 s incubation period and the change in absorbance at 340 nm measured between ()·S sand 100 s. Reagent consisted of rabbit antiserum to human albumin (Dakopatts, DK-26!1O Glostrup, Denmark) diluted 80-fold in sodium barbitone buffer (0,1 M, pH 8,0) containing 4% (w/v) polyethylene glycol 6!)()0 (BDH Chemicals, Poole, UK). Results were calculated from absorbance changes produced by eight standard albumin solutions [Dade diagnostics human protein standard (American Hospital Supply UK, Ltd, Compton, Berks, UK») in the range 3-180 mglL in ()·9'10 NaCI. Controls were urines spiked with albumin.
RIA
Albumin was measured in the same batch using the DPC kit in accordance with the manufacturer's instructions. A full evaluation has been previously described." STATISTICAL ANAI.YSIS Linear regression analysis was carried out by Bartlett procedure for bivariate data sets, and paired r-test for statistical comparison.
Resu/ls and discussion
Between-batch CV by the IT assay was 5, 3·4, 5'X. for albumin concentrations of 10·2, 41·5.
Lloyd et al.
102 mg/L respectively, and within-batch CY 2·7, 1·6,0,6% for albumin concentrations of 20, 3S, 90 mgIL respectively. Recovery of albumin from urine, added at concentrations of 80, SO and 20 mg/L, was 103, 104 and 95'Yo respectively by the IT method. and the limit of detection, the lowest concentration distinguishable from blank, was 4 mg/L.
Results obtained using the IT procedure were slightly higher than those of the RIA [9·12±7·6 (mean±lSO), range 4-3S·S mg/L, 8·S9±6·9, range 1-30·9 mg/L respectively) but were not statistically significantly different (P>O·OS). Albumin results from the non-diabetic group ranged from undetectable to 18 mg/L (8·9±4·0, mean±JSO). Correlation between the methods for albumin concentrations, which were mainly within the range found in the non-diabetic population, was good (r=0·94, IT=O'986 RIA-0·6). The IT assay is rapid, taking approximately IS min to screen and analyse 30 specimens, and the cost per test is less than lOp, compared with the RIA method which takes in excess of 1 h, and costs approximately £1·00 per test. Stock reagents are very stable [albumin standards of S·3, 84·5, 169 mg/L had absorbances of 0·9±0·OSS, 17·2S±0·95, 28·S2±1·45 mg/L (mean x J()2± ISO) respectively calculated from nine assays in one month), and whilst the same batch of antiserum is used, calibration is not essential with each analysis.
